PARTNERS GROUP N/ CH0024608827 /
1/7/2025 5:30:07 PM | Chg. +8.00 | Volume | Bid8:26:25 AM | Ask8:26:25 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,268.50CHF | +0.63% | 174,221 Turnover: 227.56 mill. |
-Bid Size: 110 | -Ask Size: 106 | 33.87 bill.CHF | 3.07% | 32.78 |
GlobeNewswire
8/21/2024
Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market ...
GlobeNewswire
8/2/2024
Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock
GlobeNewswire
8/1/2024
Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock
GlobeNewswire
6/14/2024
Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing
GlobeNewswire
5/30/2024
Wendover Management Now Accepting Applications for Weston 4 Hundred in Kissimmee
GlobeNewswire
5/28/2024
Actuate Therapeutics Files Registration Statement for Initial Public Offering
GlobeNewswire
5/21/2024
Invidia Capital Management Announces Healthcare Investment Firm Launch with Strategic Investment fro...
GlobeNewswire
5/17/2024
Aqua Metals Announces Closing of $8.05 Million Public Offering of Common Stock, Including Full Exerc...
GlobeNewswire
5/3/2024
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approxima...
GlobeNewswire
5/1/2024
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Mark...
GlobeNewswire
3/14/2024
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
GlobeNewswire
3/12/2024
Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock